Jounce Therapeutics

Office Administrator

Job ID
2021-1254
Category
Administrative/Clerical
Job Location
US-MA-Cambridge

Role / Responsibilities

The Office Administration team at Jounce is hiring! We are seeking an Office Administrator who will serve as the first point of contact for the Company and will set the tone of the reception area for visitors. She/he will be responsible for the office environment including managing supplies, ordering food and organizing companywide events. The ideal candidate will be warm, welcoming, outgoing and highly organized. This position requires polished communication skills, exceptional attention to detail, good judgment, and the ability to manage within a very dynamic, fast-paced environment, with constantly evolving priorities. We are looking for a team player who is energetic, proactive and hardworking. This role will require onsite presence 5 days a week during business hours (9 a.m. – 5 p.m. ET).

  • Greet, register and direct visitors to appropriate parties; active presence at
    the front desk for majority of the workday required.
  • Answer phones and direct calls accordingly.
  • Sort and deliver incoming mail.
  • Track, order and maintain storage areas for office supplies.
  • Manage food and kitchen supply program including monitoring and ordering snacks and groceries, receiving and unpacking weekly and daily food deliveries, and overall upkeep of refrigerators and snack area.
  • Collect, organize and update content for Company intranet site.
  • Assist Human Resources with onboarding/offboarding process.
  • Create and maintain security badges.
  • General administrative team and back-up support.
  • Assist with companywide events including happy hours, Company meetings, offsites, etc. and responsible for conference room and common area upkeep.
  • Order swag for new hires and companywide events / yearly Company gift.

Qualifications

  • Minimum of 1 year of administrative experience in a fast-paced environment.
  • Excellent technical skills with a flair for using latest technology and a passion
    to learn new efficient ways of getting things done.
  • Experience with MS Office Suite: Word, Excel, PowerPoint and Outlook.
  • Flexible and highly organized with a proven ability to professionally juggle
    multiple competing tasks and demands.
  • Strong written, interpersonal and verbal communication skills and ability to
    effectively deal with various personnel inside and outside the Company.
  • Must be a self-starter with a positive and flexible “can do” attitude and a
    willingness to independently perform a wide range of tasks

Statement

Jounce Therapeutics is an equal opportunity employer and does not discriminate in its employment decisions on the basis of race, color, national origin, age, physical or mental disability, marital status, religion, creed, sex, or political beliefs. We offer a competitive salary and benefits package. All applicants should be legally entitled to work for any employer in the U.S.

Company Summary

Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long-lasting benefits to patients through a biomarker-driven approach. Jounce currently has multiple development stage programs ongoing while simultaneously advancing additional early-stage assets from its robust discovery engine based on its Translational Science Platform. Jounce’s highest priority program, JTX-8064, is a LILRB2 (ILT4) receptor antagonist shown to reprogram immune-suppressive tumor associated macrophages to an anti-tumor state in preclinical studies. A Phase 1 clinical trial, named INNATE, for JTX-8064 as a monotherapy and in combination with JTX-4014, Jounce’s internal PD-1 inhibitor, or pembrolizumab is currently enrolling patients with advanced solid tumors. Jounce’s most advanced product candidate, vopratelimab, is a monoclonal antibody that binds to and activates ICOS, and is currently being studied in the SELECT Phase 2 trial. JTX-4014 is a PD-1 inhibitor intended for combination use in the INNATE and SELECT trials and with Jounce’s broader pipeline. Additionally, Jounce exclusively licensed worldwide rights to JTX-1811, a monoclonal antibody targeting CCR8 and designed to selectively deplete T regulatory cells in the tumor microenvironment, to Gilead Sciences, Inc. For more information, please visit www.jouncetx.com.

Options

Sorry the Share function is not working properly at this moment. Please refresh the page and try again later.
Share on your newsfeed